These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26428226)

  • 1. iPSC-based drug screening for Huntington's disease.
    Zhang N; Bailus BJ; Ring KL; Ellerby LM
    Brain Res; 2016 May; 1638(Pt A):42-56. PubMed ID: 26428226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
    Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
    Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.
    Liu L; Huang JS; Han C; Zhang GX; Xu XY; Shen Y; Li J; Jiang HY; Lin ZC; Xiong N; Wang T
    Mol Neurobiol; 2016 Dec; 53(10):6698-6708. PubMed ID: 26659595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
    Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
    Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy.
    Csobonyeiova M; Polak S; Danisovic L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32213859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
    Geater C; Hernandez S; Thompson L; Mattis VB
    Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.
    Tousley A; Kegel-Gleason KB
    J Huntingtons Dis; 2016 Jun; 5(2):99-131. PubMed ID: 27372054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Huntington's disease with induced pluripotent stem cells.
    Kaye JA; Finkbeiner S
    Mol Cell Neurosci; 2013 Sep; 56():50-64. PubMed ID: 23459227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
    Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
    Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Huntington׳s disease with patient-derived neurons.
    Mattis VB; Svendsen CN
    Brain Res; 2017 Feb; 1656():76-87. PubMed ID: 26459990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
    Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
    Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.
    An MC; Zhang N; Scott G; Montoro D; Wittkop T; Mooney S; Melov S; Ellerby LM
    Cell Stem Cell; 2012 Aug; 11(2):253-63. PubMed ID: 22748967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.
    Dabrowska M; Ciolak A; Kozlowska E; Fiszer A; Olejniczak M
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics.
    Akimov SS; Jiang M; Kedaigle AJ; Arbez N; Marque LO; Eddings CR; Ranum PT; Whelan E; Tang A; Wang R; DeVine LR; Talbot CC; Cole RN; Ratovitski T; Davidson BL; Fraenkel E; Ross CA
    Hum Mol Genet; 2021 Nov; 30(24):2469-2487. PubMed ID: 34296279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.
    HD iPSC Consortium
    Cell Stem Cell; 2012 Aug; 11(2):264-78. PubMed ID: 22748968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced Pluripotent HD Monkey Stem Cells Derived Neural Cells for Drug Discovery.
    Kunkanjanawan T; Carter R; Ahn KS; Yang J; Parnpai R; Chan AWS
    SLAS Discov; 2017 Jul; 22(6):696-705. PubMed ID: 28027448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alterations mediate iPSC-induced normalization of DNA repair gene expression and TNR stability in Huntington's disease cells.
    Mollica PA; Zamponi M; Reid JA; Sharma DK; White AE; Ogle RC; Bruno RD; Sachs PC
    J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29898922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease.
    Malakhova AA; Grigor'eva EV; Malankhanova TB; Pavlova SV; Valetdinova KR; Abramycheva NY; Vetchinova AS; Illarioshkin SN; Zakian SM
    Stem Cell Res; 2020 Apr; 44():101743. PubMed ID: 32179492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an induced pluripotent stem cell line from a Huntington's disease patient with a long HTT-PolyQ sequence.
    Miller DC; Lisowski P; Genehr C; Wanker EE; Priller J; Prigione A; Diecke S
    Stem Cell Res; 2023 Apr; 68():103056. PubMed ID: 36863131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.